![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EPIGENOMICS AG ANNOUNCES CONTINUATION OF PHARMACEUTICAL BIOMARKER RESEARCH COLLABORATION
EPIGENOMICS AG ANNOUNCES CONTINUATION OF PHARMACEUTICAL BIOMARKER RESEARCH COLLABORATION
May 16, 2006
Epigenomics AG, a molecular diagnostics company developing tests based on DNA methylation, announced today that the company has entered into an agreement to continue a collaboration with AstraZeneca Ltd. to identify and analyse potential DNA methylation biomarker candidates for use in AstraZeneca's oncology programs.
The Houston Chronicle (http://www.chron.com/disp/story.mpl/conws/3866430.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct